TickerFacts.

Biogen Inc. (BIIB): Operating Income

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Operating Income is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$2.84B
Year ended 2021-12-31
-21.6%
3-year compound annual growth
-11.2%
5-year compound annual growth
+5.1%
10-year compound annual growth
$7.04B2007-12-31: $779.77M2008-12-31: $1.21B2009-12-31: $1.30B2010-12-31: $1.25B2011-12-31: $1.72B2012-12-31: $1.86B2013-12-31: $2.52B2014-12-31: $3.97B2015-12-31: $4.89B2016-12-31: $5.15B2017-12-31: $5.35B2018-12-31: $5.89B2019-12-31: $7.04B2020-12-31: $4.55B2021-12-31: $2.84B$2.84B
2007-12-31 Operating Income (USD) 2021-12-31
Period endedOperating IncomeChange YoYSource filing
2021-12-31$2.84B-37.6%2022-02-03, From 2021-01-01
2020-12-31$4.55B-35.4%2022-02-03, From 2020-01-01
2019-12-31$7.04B+19.6%2022-02-03, From 2019-01-01
2018-12-31$5.89B+10.2%2021-02-03, From 2018-01-01
2017-12-31$5.35B+3.8%2020-02-06, From 2017-01-01
2016-12-31$5.15B+5.3%2019-02-06, From 2016-01-01
2015-12-31$4.89B+23.1%2018-02-01, From 2015-01-01
2014-12-31$3.97B+57.9%2017-02-02, From 2014-01-01
2013-12-31$2.52B+35.5%2016-02-03, From 2013-01-01
2012-12-31$1.86B+7.6%2015-02-04, From 2012-01-01
2011-12-31$1.72B+38.1%2014-02-06, From 2011-01-01
2010-12-31$1.25B-3.6%2013-02-05, From 2010-01-01
2009-12-31$1.30B+6.7%2012-02-03, From 2009-01-01
2008-12-31$1.21B+55.6%2011-02-04, From 2008-01-01
2007-12-31$779.77Mn/a2010-02-09, From 2007-01-01